Supplementary Table 1. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines

Name: Supplementary Table 1. Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines
Creator: Taylor & Francis
Published: 2021-05-14T09:24:33+08:00

DataCite Commons2024-05-16 更新2025-04-15 收录

EGFR突变肺癌靶向治疗

真实世界证据

数据链接：

https://tandf.figshare.com/articles/dataset/Supplementary_Table_1_Real-world_data_on_treatment_outcomes_in_EGFR-mutant_non-small-cell_lung_cancer_patients_receiving_osimertinib_in_second_or_further_lines/14595804/1 数据链接链接失效反馈

官方服务：

资源简介：

<b>Supplementary Table 1</b>. Real world data on treatment outcomes in EGFR mutant NSCLC patients receiving osimertinib in second or further lines Treatment response in T790M positive and T790M negative patients.

提供机构：

Taylor & Francis

创建时间：

2021-05-14